ClinicalTrials.Veeva

Menu

Sealing of Initial Occlusal Caries Using Fissure Sealants

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Caries; Initial

Treatments

Other: 3M™ Clinpro™ Sealant.
Other: BioCoat® by Premier®

Study type

Interventional

Funder types

Other

Identifiers

NCT05891288
Bioactive fissue sealant

Details and patient eligibility

About

The purpose of this study is to compare the performance of newly introduced bioactive resin based pits and fissure sealant versus fluoride releasing resin based pits and fissure sealant in initial carious lesions of fissures in posterior molars in patients at risk of caries. Visual tactile examination and VistaCAM will be used for evaluation.

Full description

SmartCap™ Technology, which is used in the novel bioactive fissure sealant, is based on proprietary semi-permeable resin microcapsules. The rechargeable SmartCap microcapsules in BioCoat are packed with ionic fluoride, calcium, and phosphate solutions that diffuse in and out of the sealant. It is hypothesized that fluoride uptake is increased in the presence of calcium and phosphate ions.

With little evidence-based information in the literature about using bioactive fissure sealants to seal initial carious lesions, it was determined that a randomized controlled trial would be beneficial in testing the null hypothesis that bioactive resin pits and fissure sealant will have the same clinical performance as fluoride releasing resin-based pits and fissure sealant in fissures with initial caries.

Enrollment

64 patients

Sex

All

Ages

19 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with bilateral initial carious fissures in molars showing no signs of caries.
  • Co-operative patients approving to participate in the trial.

Exclusion criteria

  • Sound fissures.
  • Pregnancy.
  • Disabilities.
  • Systemic disease or severe medical complications.
  • Rampant caries.
  • Heavy smoking.
  • Xerostomia.
  • Lack of compliance.
  • Evidence of severe bruxism, clenching, or tempromandibular joint disorders.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

64 participants in 2 patient groups

bioactive group
Experimental group
Description:
Bioactive Pits \& fissures sealant BioCoat® by Premier®.
Treatment:
Other: BioCoat® by Premier®
Comparator group
Active Comparator group
Description:
Fluoride releasing resin based Pits \& fissures sealant 3M™ Clinpro™ Sealant
Treatment:
Other: 3M™ Clinpro™ Sealant.

Trial contacts and locations

1

Loading...

Central trial contact

Omar Shaalan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems